Wexford Capital’s Medtronic MDT Stock Holding History

Wexford Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-20,525	Closed	-$1.65M	–	231
2023 Q1	$1.65M	Buy	+20,525	New	+$1.67M	0.34%	57

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wexford Capital's MDT Position: Q2 2023 in Review

Wexford Capital sold out of Medtronic (MDT) in Q2 2023, closing a stake of 20,525 shares — an estimated $1.65M sold.

Wexford Capital first reported a position in MDT in Q1 2023 and held it in 1 quarter. The position peaked at $1.65M in Q1 2023. 2,056 funds tracked by Wall St. Rank hold MDT as of Q2 2023.

Wexford Capital reported no remaining Medtronic position as of Q2 2023 after selling out during the quarter.
Wexford Capital sold 20,525 Medtronic shares in Q2 2023, an estimated $1.65M.
Wexford Capital first reported a position in Medtronic in Q1 2023 and held it in 1 quarter.
Wexford Capital's Medtronic position peaked at $1.65M in Q1 2023.
2,056 funds tracked by Wall St. Rank held Medtronic as of Q2 2023.

Based on Wexford Capital's 13F filing for Q2 2023, filed 14 Aug 2023.